Transforming growth factor β-inhibitor Repsox downregulates collagen expression of scleroderma dermal fibroblasts and prevents bleomycin-induced mice skin fibrosis

The expression of miR-124 increases in aged skin to cause cell senescence and it decreases in squamous cell carcinoma

(2016) Miho Harada et al.   BioScience Trends

Decreased Interleukin-20 Expression in Scleroderma Skin Contributes to Cutaneous Fibrosis

(2014) Hideo Kudo et al.   Arthritis & Rheumatology

A New Class of Small Molecule Inhibitor of BMP Signaling

(2013) Caroline E. Sanvitale et al.   PLoS One

miR-150 Down-Regulation Contributes to the Constitutive Type I Collagen Overexpression in Scleroderma Dermal Fibroblasts via the Induction of Integrin β3

(2012) Noritoshi Honda et al.   AMERICAN JOURNAL OF PATHOLOGY

JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis

(2012) Clara Dees et al.   ARTHRITIS AND RHEUMATISM

TGF- -Mediated Downregulation of MicroRNA-196a Contributes to the Constitutive Upregulated Type I Collagen Expression in Scleroderma Dermal Fibroblasts

(2012) N. Honda et al.   JOURNAL OF IMMUNOLOGY

Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis

(2011) Jérôme Avouac et al.   ARTHRITIS AND RHEUMATISM

Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway

(2010) Chihiro Tanaka et al.   ARTHRITIS AND RHEUMATISM

A novel glycosylation signal regulates transforming growth factor   receptors as evidenced by endo- -galactosidase C expression in rodent cells

(2010) S. Watanabe et al.   GLYCOBIOLOGY

Mechanisms of skin fibrosis in systemic sclerosis

(2010) Masatoshi JINNIN   JOURNAL OF DERMATOLOGY

Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis

(2009) M. Jinnin et al.   BRITISH JOURNAL OF DERMATOLOGY

A Small-Molecule Inhibitor of Tgf-β Signaling Replaces Sox2 in Reprogramming by Inducing Nanog

(2009) Justin K. Ichida et al.   Cell Stem Cell